| 000 | 01553 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517001211.0 | ||
| 264 | 0 | _c20150917 | |
| 008 | 201509s 0 0 eng d | ||
| 022 | _a1399-6576 | ||
| 024 | 7 |
_a10.1111/aas.12425 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJuhl-Olsen, P | |
| 245 | 0 | 0 |
_aEffects of levosimendan in patients with left ventricular hypertrophy undergoing aortic valve replacement. _h[electronic resource] |
| 260 |
_bActa anaesthesiologica Scandinavica _cJan 2015 |
||
| 300 |
_a65-77 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAortic Valve _xsurgery |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHeart Valve Prosthesis Implantation |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrazones _xadverse effects |
| 650 | 0 | 4 |
_aHypertrophy, Left Ventricular _xphysiopathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyridazines _xadverse effects |
| 650 | 0 | 4 | _aSimendan |
| 700 | 1 | _aJakobsen, C-J | |
| 700 | 1 | _aRasmussen, L A | |
| 700 | 1 | _aBhavsar, R | |
| 700 | 1 | _aKlaaborg, K-E | |
| 700 | 1 | _aFrederiksen, C A | |
| 700 | 1 | _aSloth, E | |
| 773 | 0 |
_tActa anaesthesiologica Scandinavica _gvol. 59 _gno. 1 _gp. 65-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/aas.12425 _zAvailable from publisher's website |
| 999 |
_c24309107 _d24309107 |
||